Skip to content

FP7H2020HORIZON

Universitatsklinikum Erlangen

Country
DEGermany
Defence projects
0
Projects, all programmes
66
As coordinator
16
EU contribution (CORDIS)
EUR 39,446,443
Active
2008 to 2025

Projects

66 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
BARRIER BREAKBreaking the barrier: How inflammation spreads from skin to jointH20202020CoordinatorEUR 1,487,231
RESCUERRESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.H20202020ParticipantEUR 245,713
NeutroCureDevelopment of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.H20202020ParticipantEUR 547,054
AMELIEAnchored Muscle cELls for IncontinencEH20202020ParticipantEUR 114,844
Degradation_IDThe role of protein degradation in FBXO11-related intellectual disabilityH20202019ParticipantEUR 131,105
MOBILISE-DConnecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsementH20202019ParticipantEUR 1,125,055
EUPHORIAEnhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal AbnormalitiesH20202019ParticipantEUR 511,999
4-D nanoSCOPEAdvancing osteoporosis medicine by observing bone microstructure and remodelling using a four-dimensional nanoscopeH20202019CoordinatorEUR 2,837,980
ONCOBIOMEGut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.H20202019ParticipantEUR 412,158
PRECODEPancREatic Cancer OrganoiDs rEsearch NetworkH20202019CoordinatorEUR 252,788
ID-EPTRIInfradev - European Paediatric Translational Research InfrastructureH20202018ParticipantEUR 103,750
VGAPThe Viral Genome Associated ProteomeH20202017CoordinatorEUR 171,461
TIN-ACTResearch School for TINnitus Assessment, Causes and TreatmentsH20202017ParticipantEUR 498,433
RTCureRheuma Tolerance for CureH20202017ParticipantEUR 449,730
BEAt-DKDBiomarker Enterprise to Attack DKD - Sofia ref.: 115974H20202016ParticipantEUR 387,500
PREFERPatient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966H20202016ParticipantEUR 230,722
PANGPathogen and GrapheneH20202016ParticipantEUR 45,000
SOSSorting of SelfH20202015CoordinatorEUR 1,479,781
APPROACHApplied Public-Private Research enabling OsteoArthritis Clinical HeadwayFP72015ParticipantEUR 35,000
EAVI2020European AIDS Vaccine Initiative 2020H20202015ParticipantEUR 564,021

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.